Journal
Translational Neurodegeneration
Publication Date
5-12-2023
Volume
12
Issue
1
First Page
24
Document Type
Open Access Publication
DOI
10.1186/s40035-023-00358-w
Rights and Permissions
LaBarbera, K.M., Sheline, Y.I., Izzo, N.J. et al. A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer’s disease using an indwelling CSF catheter. Transl Neurodegener 12, 24 (2023). https://doi.org/10.1186/s40035-023-00358-w This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Recommended Citation
LaBarbera, Kelsie M; Yuede, Carla M; Edwards, Hannah M; Gardiner, Woodrow D; Cirrito, John R; and et al., "A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheter." Translational Neurodegeneration. 12, 1. 24 (2023).
https://digitalcommons.wustl.edu/oa_4/2817
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
